Bordet Scientific Publications

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) Penninckx Sébastien
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.
Auteurs Schoenauen L, Stubbe FX, Van Gestel D, Penninckx S, Heuskin AC
Auteurs (entité) VAN GESTEL DIRK
Revue Clin Transl Radiat Oncol
Date de publication 2024-03

C. elegans: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) VEYS ISABELLE
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LIBERALE GABRIEL
Revue Breast Cancer Res Treat
Date de publication 2024-01

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.
Auteurs Pop CF, Veys I, Bormans A, Larsimont D, Liberale G
Auteurs (entité) LARSIMONT DENIS
Revue Breast Cancer Res Treat
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) DELEU ANNE-LEEN
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) PICCART MARTINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) FLAMEN PATRICK
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).
Auteurs Mileva M, de Vries EGE, Guiot T, Wimana Z, Deleu AL, Schröder CP, Lefebvre Y, Paesmans M, Stroobants S, Huizing M, Aftimos P, Tol J, Van der Graaf WTA, Oyen WJG, Vugts DJ, Menke-van der Houven van Oordt CW, Brouwers AH, Piccart-Gebhart M, Flamen P, Gebhart G
Auteurs (entité) GEBHART GERALDINE
Revue NPJ Breast Cancer
Date de publication 2024-01

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmus Hospital

View all of Erasmus's scientific publications

Erasmus's academic publications

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital

Scientific publications from the Queen Fabiola Children's Hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Scientific publications by Jules Bordet

Bordet Scientific Publications

Bordet Scientific Publications

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmus Hospital

Queen Fabiola Children's Hospital

Jules Bordet Institute

Bordet Scientific Publications

Bordet Scientific Publications

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

<i>C. elegans</i>: A potent model for high-throughput screening experiments investigating the FLASH effect.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Fluorescence imaging for real-time detection of breast cancer tumors using IV injection of indocyanine green with non-conventional imaging: a systematic review of preclinical and clinical studies of perioperative imaging technologies.

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial).

Erasmus Hospital

Queen Fabiola Children's Hospital

Jules Bordet Institute

Search for a keyword

Please select a hospital